Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Varda Sandweiss is active.

Publication


Featured researches published by Varda Sandweiss.


Drug Development and Industrial Pharmacy | 2003

Comparison of the Flow Properties of Aqueous Suspension Corticosteroid Nasal Sprays Under Differing Sampling Conditions

Stefan A. Sharpe; Varda Sandweiss; J. Tuazon; M. Giordano; L. Witchey-Lakshmanan; John L. Hart; Joel A. Sequeira

Abstract Many aqueous suspension corticosteroid nasal sprays become less viscous when shaken and sprayed, then return to a more viscous state after application. This time-dependent, reversible loss of viscosity under shear (e.g., shaking or spraying) can be quantified in the rheological property of thixotropy. The flow properties of 5 corticosteroid nasal sprays were measured over a range of shear rates. The formulations tested included Nasonex®, Vancenase® AQ, Nasacort® AQ, Rhinocort Aqua®, and Flonase®. The yield stress values, as well as an estimate of thixotropy, were compared by using three different sampling techniques, including one that simulated patient use (shaking for 30 sec, spraying, and immediately transferring the sample to the rheometer). The rheological properties of all products indicated that when initially shaken and dispensed, they flowed more freely, followed by recovery of viscosity that would likely inhibit the suspensions from flowing out of the nasal cavity. Under all three tested conditions, Nasonex exhibited the highest yield stress, the largest apparent initial and final viscosities, and the highest apparent thixotropy. The study protocol that simulated patient-use conditions produced the following rank order of measured thixotropy: Nasonex>Flonase>Vancenase AQ>Rhinocort Aqua>Nasacort AQ. The thixotropy of Nasonex was 3.4 to 21.4 times greater and the final viscosity was 3.2 to 17.4 times greater than the values of the other tested products.


Archive | 1999

Compositions Comprising Viruses and Methods for Concentrating Virus Preparations

Andreas Frei; Henry K. H. Kwan; Varda Sandweiss; Gary Vellekamp; Pui-Ho Yuen; Laureano L. Bondoc; Frederick William Porter; John Chu-Tay Tang; Peter M. Ihnat


Archive | 2005

Particulate-stabilized injectable pharmaceutical compositions of Posaconazole

Leonore C. Witchey-Lakshmanan; Sydney Ugwu; Varda Sandweiss; Catherine Hardalo; Roberta S. Hare; Gopal Krishna; Zaiqi Wang; Marco Taglietti


Archive | 2005

Injectable pharmaceutical suspension comprising posaconazole

Leonore C. Witchey-Lakshmanan; Sydney Ugwu; Varda Sandweiss; Catherine Hardalo; Roberta S. Hare; Gopal Krishna; Zaiqi Wang; Marco Taglietti


Archive | 1984

Betamethasone dipropionate cream

Varda Sandweiss; Elliot I. Stupak; Paul Hyman Shapiro


Archive | 2002

Syn3 compositions and methods

Peter M. Ihnat; Leonore C. Witchey-Lakshmanan; Varda Sandweiss; Sydney Ugwu


Archive | 2010

Syn3 composition and method for the same

Peter M. Ihnat; Varda Sandweiss; Sydney Ugwu; Leonore C. Witchey-Lakshmanan; オー. ウグー シドニー; サンドウェイス バーダ; エム. イーナット ピーター; シー. ウィッチー−ラクシュマナン レオノア


Archive | 2005

Compositions pharmaceutiques injectables particulaires stabilisees de posaconazole

Leonore C. Witchey-Lakshmanan; Sydney Ugwu; Varda Sandweiss; Catherine Hardalo; Roberta S. Hare; Gopal Krishna; Zaiqi Wang; Marco Taglietti


Archive | 2003

Nasal formulations for the treatment of allergies

Stefan A. Sharpe; Joel A. Sequeira; Varda Sandweiss; Mark C. Giordano; Saeed Chaudhry


Archive | 2002

Syn3-zusammensetzungen und verfahren

Peter M. Ihnat; Leonore C. Witchey-Lakshmanan; Varda Sandweiss; Sydney Ugwu

Collaboration


Dive into the Varda Sandweiss's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge